Moving forward, research may increasingly focus on DKD and membranous nephropathy (MN), potentially emphasizing the NF-κB (Nuclear Factor kappa-light-chain-enhancer of activated B cells) pathway. The gene discussed is NFKB1; the disease is diabetic kidney disease.